Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
RbAbqNvXRqcg882C